AnHeart is a China-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Business Model:
Revenue: $3.5M
Employees: 51-200
Address: 118 Ruijin Second Road
City: Shanghai
State: shanghai municipality
Zip: 200021
Country: CN
AnHeart is a China-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2019 | Series A | 1 | $14.6M |
Decheng Capital Decheng Capital Decheng Capital Decheng Capital |
3/2020 | Series A | $20M |
Decheng Capital |
8/2020 | Series A | $10M | 12/2021 | Series B | $0 |
Cenova Innovent Biologics Laurion Capital Management Octagon Capital Advisors Sage Partners Cenova Innovent Biologics Laurion Capital Management Octagon Capital Advisors Sage Partners |
6/2019 | Seed | $9M | 12/2021 | Series B | 5 | $61M |
Octagon Capital Innovent Biologics Cenova Laurion Capital Sage Partners Cenova Innovent Biologics Laurion Capital Management Octagon Capital Advisors Sage Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|